As the Trump administration took the reins of power, the health care industry faced a period of unprecedented uncertainty, driven by the potential impacts of new policies on various sectors, including hospitals and pharmaceuticals. With the Republicans gaining control of the White House and
The healthcare landscape is evolving, with a growing emphasis on treating the "whole person" rather than just addressing physical symptoms. This shift is particularly evident in the Veterans Health Administration (VA), which is adopting a "Whole Health" approach to better meet the comprehensive
The U.S. Supreme Court's decision in June 2024 to overturn Chevron deference marks a significant shift in the landscape of health care regulation. This legal doctrine, established in 1984, allowed federal agencies to interpret ambiguous statutes enacted by Congress and develop regulations for
Former President Donald Trump has recently sparked significant debate by suggesting that, should he secure another term in office, Robert F. Kennedy Jr. (RFK Jr.) might play a pivotal role in shaping U.S. health policies. Trump's statements have raised questions about how RFK Jr.'s controversial
The White House has unveiled an ambitious policy proposal aimed at expanding access to over-the-counter birth control for millions of Americans with private health insurance. Spearheaded by the U.S. Department of Health and Human Services, the proposed rule presents a landmark shift in national
Pharmaceutical advertising plays an increasingly influential role in the healthcare decisions of patients and the practice of medicine by physicians. A recent survey conducted by Magna and DeepIntent, encompassing over 2,000 participants, sheds light on the multifaceted effects of
